Home › Chronic Kidney Disease › Alabama › Huntsville
Chronic Kidney Disease clinical trials in Huntsville, AL
4 studies for Chronic Kidney Disease are looking for participants at sites in and around Huntsville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Heart Center Research, LLC, Huntsville
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
RecruitingPhase 3
- Research Site, Huntsville
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- Apogee Clinical Research, LLC, Huntsville
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
RecruitingPhase 3
- Research Site, Huntsville
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY17 studies
- Boston, MA15 studies
- Dallas, TX15 studies
- Houston, TX15 studies
- Philadelphia, PA15 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA10 studies
- Durham, NC9 studies
- Kansas City, MO9 studies
- San Antonio, TX8 studies
- Albuquerque, NM8 studies
Other studies in Huntsville
- Cardiovascular Disease8 studies
- Obesity7 studies
- Coronary Artery Disease6 studies
- Heart Failure6 studies
- Major Depressive Disorder6 studies
- Type 2 Diabetes6 studies
- Depression6 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Aortic Valve Stenosis4 studies
- Heart Attack3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.